Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
- PMID: 38020909
- PMCID: PMC10666747
- DOI: 10.3389/fcell.2023.1289063
Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
Abstract
Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored, together with screening and identification of potential functional peptides via bioinformatics analysis. Materials and methods: A total of 12 patients who underwent in vitro fertilization and embryo transfer (IVF-ET) at the Reproductive Medicine Center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from 1 September 2022 to 1 November 2022 were included in this study. The follicular fluid of PCOS patients (n = 6) and normal women (n = 6) were collected. The presence and concentration differences of various peptides were detected by the LC-MS/MS method. GO and KEGG analysis were performed on the precursor proteins of the differentially-expressed peptides, and protein network interaction analysis was carried out to identify functionally-relevant peptides among the various peptides. Results: A variety of peptides within the follicular fluid of PCOS versus normal patients were detected by peptidomics techniques. Altogether, 843 upregulated peptides and 236 downregulated peptides were detected (absolute fold change ≥2 and p < 0.05). Of these, 718 (718 = 488 + 230) peptides were only detected in the PCOS group, while 205 (205 = 174 + 31) were only detected in the control group. Gene Ontology enrichment and pathway analysis were performed to characterize peptides through their precursor proteins. We identified 18 peptides from 7 precursor proteins associated with PCOS, and 4 peptide sequences were located in the functional domains of their corresponding precursor proteins. Conclusion: In this study, differences in the follicular development of PCOS versus normal patients were revealed from the polypeptidomics of follicular development, which thus provided new insights for future studies on the pathological mechanisms of PCOS development.
Keywords: assisted reproduction; follicular fluid; in vitro fertilization; peptidomics analysis; polycystic ovarian syndrome.
Copyright © 2023 Sun, Chen, Lu, Yan, Zhou, Li, Zhang, Yuan, Heng, Zeng, Shi, Tong and Yin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.Hum Reprod. 2018 Sep 1;33(9):1735-1748. doi: 10.1093/humrep/dey255. Hum Reprod. 2018. PMID: 30052945
-
Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.Hum Reprod. 2020 Jul 1;35(7):1655-1665. doi: 10.1093/humrep/deaa098. Hum Reprod. 2020. PMID: 32558920 Free PMC article.
-
Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome.Reprod Biomed Online. 2018 Apr;36(4):483-489. doi: 10.1016/j.rbmo.2017.12.020. Epub 2018 Jan 20. Reprod Biomed Online. 2018. PMID: 29397316
-
Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome.Front Mol Biosci. 2022 Aug 22;9:956406. doi: 10.3389/fmolb.2022.956406. eCollection 2022. Front Mol Biosci. 2022. PMID: 36072434 Free PMC article.
-
Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.Biomedicines. 2022 May 27;10(6):1254. doi: 10.3390/biomedicines10061254. Biomedicines. 2022. PMID: 35740276 Free PMC article. Review.
References
-
- Alan M., Gurlek B., Yilmaz A., Aksit M., Aslanipour B., Gulhan I., et al. (2019). Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 35, 220–223. 10.1080/09513590.2018.1512967 - DOI - PubMed
-
- Aslanipour B., Alan M., Demir I. (2020). Decreased levels of liver-expressed antimicrobial peptide-2 and ghrelin are related to insulin resistance in women with polycystic ovary syndrome. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 36, 222–225. 10.1080/09513590.2019.1665646 - DOI - PubMed
LinkOut - more resources
Full Text Sources